Mostrar el registro sencillo del ítem
dc.contributor.author | García Apac, Coralith Marlinda | |
dc.contributor.author | Horna, G. | |
dc.contributor.author | Linares, E. | |
dc.contributor.author | Ramírez, R. | |
dc.contributor.author | Tapia, E. | |
dc.contributor.author | Velásquez, J. | |
dc.contributor.author | Medina, V. | |
dc.contributor.author | Guevara, J. | |
dc.contributor.author | Urbina, M. | |
dc.contributor.author | Zevallos, S. | |
dc.contributor.author | Espinoza, N. | |
dc.contributor.author | Samalvides Cuba, Frine | |
dc.contributor.author | Jacobs, J. | |
dc.date.accessioned | 2022-01-18T19:34:44Z | |
dc.date.available | 2022-01-18T19:34:44Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/11199 | |
dc.description.abstract | To the Editor: In Latin American countries, rates of antimicrobial drug resistance among bacterial pathogens are high. Data on these rates in Peru are incomplete (1), and no institution in Peru has participated in multinational surveillance studies (2–4). To document the antimicrobial drug resistance profile of key pathogens, we organized a surveillance network of clinical laboratories from 9 hospitals (public, general, tertiary care, and quaternary care) in Lima, the capital of Peru. Over a 12-month period (April 2008–March 2009), we consecutively collected positive bacterial blood culture isolates (other than coagulase-negative staphylococci) from each of the 9 hospitals. Only the first isolate per patient was included. Patients’ age and hospital ward were recorded. Identification and susceptibility testing were performed at the Institute of Tropical Medicine Alexander von Humboldt (Lima, Peru)... | en_US |
dc.language.iso | eng | |
dc.publisher | Centers for Disease Control and Prevention | |
dc.relation.ispartofseries | Emerging Infectious Diseases | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Humans | en_US |
dc.subject | Peru | en_US |
dc.subject | controlled study | en_US |
dc.subject | Bacteria | en_US |
dc.subject | letter | en_US |
dc.subject | Anti-Bacterial Agents | en_US |
dc.subject | amikacin | en_US |
dc.subject | bacterium identification | en_US |
dc.subject | meropenem | en_US |
dc.subject | vancomycin | en_US |
dc.subject | Bacterial Infections | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | bacterium isolate | en_US |
dc.subject | Microbial Sensitivity Tests | en_US |
dc.subject | ciprofloxacin | en_US |
dc.subject | gentamicin | en_US |
dc.subject | antibiotic sensitivity | en_US |
dc.subject | ceftazidime | en_US |
dc.subject | cotrimoxazole | en_US |
dc.subject | antibiotic resistance | en_US |
dc.subject | clindamycin | en_US |
dc.subject | Klebsiella pneumoniae | en_US |
dc.subject | linezolid | en_US |
dc.subject | Drug Resistance, Bacterial | en_US |
dc.subject | piperacillin plus tazobactam | en_US |
dc.subject | teicoplanin | en_US |
dc.subject | erythromycin | en_US |
dc.subject | disk diffusion | en_US |
dc.subject | imipenem | en_US |
dc.subject | Klebsiella pneumoniae infection | en_US |
dc.subject | meticillin | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.subject | Sentinel Surveillance | en_US |
dc.subject | Staphylococcus aureus | en_US |
dc.title | Antimicrobial drug resistance in Peru | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.3201/eid1803.100878 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.03.08 | |
dc.relation.issn | 1080-6059 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |